Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents - Related Studies

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

This study is ongoing, but not recruiting participants.

Study NCT00708084. Last updated on October 8, 2008. Information provided by Crucell Holland BV

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Rabies

2	More general conditions related to this trial
		Mononegavirales Infections
		Rhabdoviridae Infections
		RNA Virus Infections
		Virus Diseases

3	Interventions listed in this trial
		CL184
		HRIG

4	Additional drug interventions recognized in this trial
		Immunoglobulins

5	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		Crucell Holland BV